In Vivo Evaluation of a Gastro-Resistant HPMC-Based “Next Generation Enteric” Capsule

Many orally dosed APIs are bioavailable only when formulated as an enteric dosage form to protect them from the harsh environment of the stomach. However, an enteric formulation is often accompanied with a higher development effort in the first place and the potential degradation of fragile APIs dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Rump, Adrian, Kromrey, Marie-Luise, Scheuch, Eberhard, Jannin, Vincent, Rehenbrock, Lara, Tzvetkov, Mladen Vassilev, Weitschies, Werner, Grimm, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609816/
https://www.ncbi.nlm.nih.gov/pubmed/36297435
http://dx.doi.org/10.3390/pharmaceutics14101999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609816/
https://www.ncbi.nlm.nih.gov/pubmed/36297435
http://dx.doi.org/10.3390/pharmaceutics14101999

Ejemplares similares